Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 was identified in December 2019 and declared a global pandemic by the World Health Organization in March 2020.
Type and severity of symptoms of an active COVID-19 infection vary greatly between individuals depending on the age, gender, and underlying medical conditions. The most commonly reported ones include fever, loss of smell, coughing, sore throat, shortness of breath or difficulty breathing, feeling weak or lethargic, chills, muscle pain, light-headedness or dizziness, headache, vomiting or diarrhea, slurred speech, and/or seizures. Less common symptoms include stuffy nose, conjunctivitis (pink eye), dizziness, confusion, abdominal pain, and skin rashes or discoloration of fingers or toes.
Specimen: Nasopharyngeal / oropharyngeal Swab
What the test will look for: Nucleic acids ie. RNA of Covid-19 Virus.
Process: A sample is collected from deep inside the patient’s nose and the back of the throat with a swab. The sample is then treated with chemical solutions that remove proteins and fats, leaving only the RNA present in the sample. The sample is then sent to the laboratory for analysis where an RT-PCR machine is used to detect the virus.
This is a molecular test which looks for the genetic material of the virus. Real Time-PCR test is intended for the qualitative detection of nucleic acid from the 2019-nCoV in upper and lower respiratory specimens collected from individuals who meet 2019-nCoV clinical or epidemiological criteria.